Clinical Trial Update: SINF: Peripheral Neuropathy in Cancer Survivors [Phase 1, Phase 2]

View source ↗

Summary

The SINF trial evaluating interventions for peripheral neuropathy in cancer survivors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathy

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Peripheral Neuropathy | Phase 1, Phase 2 | Status: WITHDRAWN